Altium Capital Management LP lowered its position in shares of BioLineRx Ltd. (NASDAQ:BLRX – Free Report) by 26.5% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 2,279,657 shares of the biotechnology company’s stock after selling 823,978 shares during the quarter. Altium […]
Altium Capital Management LP acquired a new stake in Alphatec Holdings, Inc. (NASDAQ:ATEC – Free Report) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 270,000 shares of the medical technology company’s stock, valued at approximately $4,212,000. Alphatec makes up approximately 2.3% of Altium Capital […]
Altium Capital Management LP purchased a new position in Avadel Pharmaceuticals plc (NASDAQ:AVDL – Free Report) during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 500,000 shares of the company’s stock, valued at approximately $4,580,000. Avadel Pharmaceuticals makes up 2.5% of Altium […]
Altium Capital Management LP lowered its position in shares of Astria Therapeutics, Inc. (NASDAQ:ATXS – Free Report) by 1.2% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,347,088 shares of the biotechnology company’s stock after selling 15,984 shares during the period. […]
Altium Capital Management LP acquired a new stake in Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS – Free Report) in the 1st quarter, according to the company in its most recent filing with the SEC. The fund acquired 228,714 shares of the biopharmaceutical company’s stock, valued at approximately $1,578,000. Altium Capital Management LP owned about 0.45% of Marinus […]